Pular para o conteúdo
Menu
Mix Vale

FDA orders recall of millions of eye drops after detection of foreign bodies

Carolina Costa
Por 2 min de leitura
Compartilhe
colírio
Foto: colírio - perfect-picture-hunter/Shutterstock.com

The United States Food and Drug Administration, the FDA, reported this Wednesday, July 9, 2026, that millions of bottles of eye drops widely used to treat allergies and inflammation in the eyes are being withdrawn from the market. The measure was taken due to the possible presence of foreign elements in the product, which generated concern among consumers and health authorities.

Publicidade

The recall specifically covers prednisolone acetate ophthalmic suspension, a medication intended to treat eye conditions. The decision to withdraw was motivated by suspicion of contamination by a foreign substance, as detailed in the official recall statement issued by the authorities.

Lupine Pharmaceuticals Inc., responsible for manufacturing the prescription medicine, is voluntarily recalling more than 2.5 million units of the product. This proactive action by the company aims to ensure patient safety and compliance with the quality standards required by health legislation.

Publicidade

As described by the Mayo Clinic, prednisolone is a steroid widely used to alleviate redness, itching and swelling resulting from infections and other eye conditions. It is essential to highlight that this medicine can only be purchased upon presentation of a medical prescription, highlighting its nature of controlled use and the importance of its integrity.

Medicine recall details

  • 5 mL vials (NDC 70748-332-02)
  • 10 mL vials (NDC 70748-332-03)
  • 15 mL vials (NDC 70748-332-04)

The medicine is manufactured by Lupine Limited, located in Pithampur, India.

The total quantity of products affected by the recall is 2,530,182 bottles, a significant number that reflects the scale of the market withdrawal operation.

The recall identification number, as recorded by authorities, is D-0655-2026.

Publicidade

This recall of eye drops involves dozens of different batch codes and bottle types, impacting a wide range of products distributed. It is recommended that patients check their medications to confirm whether they are affected.

The FDA classified the recall as Class II. This category indicates that use or exposure to the product may result in adverse health consequences that are, in most cases, temporary or medically reversible, although they require attention.

Lupine Pharmaceuticals Inc. was approached for comment on the matter, but was not immediately available to comment on the recall of the vials.

Publicidade

Carolina Costa é colaboradora da redação do Mix Vale, portal de notícias com cobertura de Brasil e mundo. Produz conteúdo nas editorias de economia e benefícios, com foco em informação de serviço para o leitor brasileiro. Escreve para o portal desde 2019. Formação: Administração

Notícias relacionadas

Mais lidas

  1. Ciência

    Meteoro no Nordeste: bólido cruza o céu de cinco estados às 21h34 e mobiliza buscas por fragmentos na Paraíba

  2. Caixa Econômica Federal

    Pé-de-Meia paga parcela de R$ 1.000,00 a aprovados no ensino médio de 2026 entre fevereiro e março de 2027

  3. Política

    Com obstrução parcial no intestino, Jair Bolsonaro é internado no hospital DF Star em Brasília

  4. INSS

    Recuperação da senha Gov.br pelo celular exige reconhecimento facial ou código por SMS para o Meu INSS

  5. EUA

    Terremoto em Los Angeles atinge magnitude 4,2 e causa tremores leves em Commerce na madrugada

  6. Matéria Publicitária

    MineMV é o novo jogo grátis de construir com blocos; veja como jogar e liberado para todas as idades

  7. Política

    Regulamentação da escala 5×2 pelo governo encarece cálculo da hora extra a partir de 16 de dezembro

  8. Santa Catarina

    Acidente de trânsito na SC-108 envolve carro e moto e deixa motociclista morto em São Ludgero

  9. Mundo

    Jornalista italiano Corrado Augias morre aos 91 anos; presidente da Itália lamenta a perda

  10. Loterias

    Rendimento de R$ 40 milhões da Mega-Sena 3088 chega a R$ 337 mil por mês no Tesouro Direto